Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision.
By J. Brożek, J. Bousquet, C. Baena-Cagnani, S. Bonini, G. Canonica, T. Casale, R. V. van Wijk, K. Ohta, T. Zuberbier, Holger J. Schünemann. Journal of Allergy and Clinical Immunology, 2010
1,573 citations recorded by the source corpus.
BACKGROUND Allergic rhinitis represents a global health problem affecting 10% to 20% of the population. The Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines have been widely used to treat the approximately 500 million affected patients globally. OBJECTIVE To develop explicit, unambiguous, and transparent clinical recommendations systematically for treatment of allergic rhinitis on the basis of current best evidence. METHODS The authors updated ARIA clinical recommendations in collaboration with Global Allergy and Asthma European Network following the approach suggested by the Grading of Recommendations Assessment, Development and Evaluation working group. RESULTS This article presents recommendations about the prevention of allergic diseases, the use of oral and topical medications, allergen specific immunotherapy, and complementary treatments in patients with allergic rhinitis as well as patients with both allergic rhinitis and asthma. The guideline panel developed evidence profiles for each recommendation and considered health benefits and harms, burden, patient preferences, and resource use, when appropriate, to formulate recommendations for patients, clinicians, and other health care professionals. CONCLUSION These are the most recent and currently the most systematically and transparently developed recommendations about the treatment of allergic rhinitis in adults and children. Patients, clinicians, and policy makers are encouraged to use these recommendations in their daily practice and to support their decisions.
Subfields: Immunology and Allergy, Physiology, Pulmonary and Respiratory Medicine
View Paper: https://www.semanticscholar.org/paper/e7f03aee61d21c5e5a12b1cc18b44789bbdcd3a4
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Immunology and Allergy
In Physiology
Citations in the corpus
- The Genetics of Asthma and Allergic Disease: A 21st Century Perspective (2011, background): “10–20% of the population, with an estimated over 500 million affected people worldwide (46, 47).”
- Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. (2012, methodology): “Real-life studies are needed to confirm that the applicability of evidence obtained in randomized controlled trials (RCTs) translates into daily practice settings.72 Pragmatic randomized trials have found that the guideline-based management of AR is more effective than free treatment choice.56 Nonet”
- Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision (2017, background): “The ARIA 2010 revision was the first evidence-based guideline in allergy to follow the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach(19) with no influence of for-profit organizations and an explicit declaration and management of potential competing interests of”
- EAACI Guidelines on Allergen Immunotherapy: Allergic rhinoconjunctivitis (2018, background): “Allergic Rhinitis and its Impact on Asthma (ARIA) categories moderate-to-severe intermittent or persistent [22]), despite avoidance measures and pharmacotherapy, that interfere with their usual daily activities or sleep.”